The cell-surface serine protease prostasin is lost during cervical squamous cell carcinogenesis
- PMID: 40828246
- DOI: 10.1007/s13577-025-01279-8
The cell-surface serine protease prostasin is lost during cervical squamous cell carcinogenesis
Abstract
The glycosylphosphatidylinositol (GPI)-anchored serine protease prostasin has been reported to have increased expression with tumor-promoting properties in some cancer types, while expression is lost and prostasin displays tumor-suppressing properties in other cancer types. Due to these context-dependent and opposing expression patterns and functions of prostasin, characterization of each cancer type is important. In the present study, we aimed to determine the expression of prostasin in the normal cervix and in cervical squamous cell carcinoma (CSCC), the most common type of cervical cancer. We found that prostasin protein is expressed in both murine and human cervix and is consistently localized on the cell surface in suprabasal layers of squamous cells in healthy cervical epithelia. To assess whether prostasin protein is differentially expressed during cervical carcinogenesis, we performed a comprehensive immunohistochemical analysis of prostasin protein expression levels and localization in tissue arrays of paraffin-embedded human cervical carcinomas compared to the corresponding normal tissue. Prostasin protein is expressed in the well-differentiated cellular strata with expression patterns similar to pan-keratin and E-cadherin, and is lost during the dedifferentiation of epithelial cells, a hallmark of high-grade CSCC. The prostasin expression profile, with differential expression in cancer, provide valuable information that may give clues to the function(s) of this protease in normal epithelial biology and carcinogenesis.
Keywords: Cell surface serine protease; Cervical squamous cell carcinoma; PRSS8; Prostasin.
© 2025. The Author(s) under exclusive licence to Japan Human Cell Society.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no competing interests.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression.Br J Dermatol. 2025 Aug 18;193(3):490-501. doi: 10.1093/bjd/ljaf108. Br J Dermatol. 2025. PMID: 40152495 Free PMC article.
-
Sun protection for preventing basal cell and squamous cell skin cancers.Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2. Cochrane Database Syst Rev. 2016. PMID: 27455163 Free PMC article.
-
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.Br J Dermatol. 2024 Dec 23;192(1):104-117. doi: 10.1093/bjd/ljae295. Br J Dermatol. 2024. PMID: 39018437 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- Wenta T, Nastaly P, Lipinska B, et al. Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression. Matrix Biol. 2024;134:197–219. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources